The poison pill termination and 20% standstill threshold signal a cooperative path forward between PIMCO and the board. Watch for any subsequent 13D amendments indicating increased stake or formal board representation demands, as well as any strategic initiatives (sale, restructuring) that PIMCO may now push more openly.
Price Chart
Executive Summary
PIMCO filed Amendment No. 10 to its Schedule 13D on FreightCar America (RAIL), reporting beneficial ownership of 48.8% of common stock as of October 14, 2026. The filing discloses an agreement with the issuer to terminate the existing stockholder rights plan and not adopt any new plan with an ownership threshold below 20%, while restricting certain transfers that would result in ownership of 20% or more without board approval. This represents a significant de-escalation of potential governance conflict, removing a poison pill that could have limited PIMCO's influence.
Key Financial Metrics
Key Facts
- PIMCO reports beneficial ownership of 48.8% of RAIL common stock as of October 14, 2026.
- PIMCO holds 15,166,643 shares of common stock plus warrants exercisable for additional shares.
- The issuer agreed to terminate its existing stockholder rights plan and not adopt any plan with an ownership threshold below 20%.
- Any sale or transfer by PIMCO that would result in a holder owning 20% or more of RAIL requires board approval.
- The agreement was entered into on October 14, 2026, and filed via the issuer's 8-K on October 15, 2026.
Financial Impact
Removal of poison pill removes a significant overhang on PIMCO's ability to increase or monetize its stake, potentially unlocking value. No specific dollar amounts disclosed.
Risk Factors
- The board approval requirement on large transfers could limit PIMCO's exit flexibility.
- No explicit demands for board seats or strategic changes were disclosed in this amendment.
- The 48.8% stake is already very high, limiting further accumulation without triggering the 20% transfer restriction.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0000902664-26-004199 |
| Document: 0000902664-26-004199-index.html | 0000902664-26-004199 |
| Document: 0000902664-26-004199.txt | 0000902664-26-004199 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Press Release | $4.12 $4.30 | ▲ +4.37% | ▲ +5.55% | $4.47 (+8.50%) |
Oct 19, 2026 7d ago | 8-K | $4.02 $4.12 | ▼ −2.62% | ▼ −2.09% | $4.47 (−11.33%) |
Oct 19, 2026 7d ago | Press Release | $4.02 $4.12 | ▼ −2.49% | ▼ −1.96% | $4.47 (−11.19%) |
Oct 16, 2026 10d ago | SC 13D/A | $5.85 $4.02 | ▼ −31.37% | ▼ −31.70% | $4.47 (−23.59%) |
Oct 15, 2026 11d ago | 8-K | $5.92 $5.85 | ▼ −1.18% | ▼ −1.61% | $4.47 (−24.49%) |
Aug 3, 2026 12w ago | Press Release | $8.54 $7.91 | ▼ −7.38% | ▼ −7.18% | $4.47 (−47.66%) |
Jun 16, 2026 19w ago | 8-K | $8.79 $9.22 | ▲ +4.89% | ▲ +6.14% | $4.47 (−49.15%) |
May 4, 2026 25w ago | 8-K | $7.72 $7.72 | · 0.00% | ▲ +1.38% | $4.47 (+42.10%) |
May 4, 2026 25w ago | Press Release | $7.72 $7.72 | · 0.00% | ▲ +1.38% | $4.47 (+42.10%) |
Apr 20, 2026 27w ago | Press Release | $8.74 $8.83 | ▲ +1.03% | ▲ +0.01% | $4.47 (−48.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers